President Donald Trump promoted hydroxychloroquine, a malaria drug, as a COVID-19 treatment. According to Reuters, several studies suggest the drug isn’t effective against COVID-19 and creates significant risks. After first using it, several U.S. hospitals have pulled back on the use of the drug. Vizient Inc, a drug buyer, said orders for the drug have dropped to a tenth of the late-March peak, to about 125,000 pills. The decrease shows that physicians no longer believe the drug’s benefits outweigh the risks.
